EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Modeling Cisplatin-Induced Kidney Injury to Increase Translational Potential

Sophia M Sears, Andrew Orwick, Leah J Siskind

Nephron · 2023 · 147 (1) · 13-16

DOI: 10.1159/000525491 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nephron, online erschienen am 06.07.2022. Verfasst von Sophia M Sears und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Toxicology, University of Louisville, Louisville, Kentucky, USA. Hauptthemen laut MEDLINE: Antineoplastic Agents, Acute Kidney Injury, Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 11 Literaturangaben. Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Cisplatin-induced kidney injury is a major challenge hindering treatment of cancer patients. Thirty percent of patients treated with cisplatin develop acute kidney injury (AKI). Even patients that do not develop AKI are at risk for long-term decline in renal function and development of chronic kidney disease. Despite researchers’ best efforts, no therapeutic agents to treat or prevent cisplatin-induced kidney injury have made it past phase 2 clinical trials. Summary: Modeling cisplatin-induced kidney injury in rodents has primarily been done using a single, high-dose model of injury. Newer models of injury have utilized repeated, low, or intermediate doses of cisplatin to incorporate the study of maladaptive repair processes following a renal insult. We believe that utilization of all these models is important to understand and treat the diverse types of cisplatin-induced kidney injury patients develop in the clinic. Incorporating comorbidities such as cancer and development of large animal models is also vital to increasing the human relevance of our studies. Key Messages: Utilizing multiple dosing models of cisplatin-induced kidney injury, including relevant comorbidities and biological variables, and development of large animal models will increase the translational potential of preclinical studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsAcute Kidney InjuryNeoplasmsAnimalsHumansCisplatinKidneyDisease Models, Animal

Stichwörter der Autor:innen

Acute kidney injuryCancerChronic kidney diseaseCisplatinPorcine models

Substanzen

CisplatinAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Pharmacology & Toxicology, University of Louisville, Louisville, Kentucky, USA.

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Sears, S. M., Orwick, A., & Siskind, L. J. (2023). Modeling Cisplatin-Induced Kidney Injury to Increase Translational Potential. Nephron, 147(1), 13-16. https://doi.org/10.1159/000525491

Vancouver

Sears SM, Orwick A, Siskind LJ. Modeling Cisplatin-Induced Kidney Injury to Increase Translational Potential. Nephron. 2023;147(1):13-16. doi:10.1159/000525491

BibTeX
@article{Sears2023,
  author = {Sears, Sophia M and Orwick, Andrew and Siskind, Leah J},
  title = {Modeling Cisplatin-Induced Kidney Injury to Increase Translational Potential},
  journal = {Nephron},
  year = {2023},
  volume = {147},
  number = {1},
  pages = {13--16},
  doi = {10.1159/000525491}
}
Kostenlos starten →